International researchers have collaborated on the first global agreement defining what specific psychosocial factors pose the “greatest impact” on psychedelic therapy, which is increasingly gaining momentum as an aid for mental health disorders. Offering a standard framework for evaluating and reporting these variables, the guidelines aim to make trial outcomes more consistent and comparable across studies. Ultimately, the scientists seek to improve the rigor and reliability of clinical research in this emergent field.
